A detailed history of Atomi Financial Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Atomi Financial Group, Inc. holds 27,835 shares of AZN stock, worth $1.87 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
27,835
Previous 21,803 27.67%
Holding current value
$1.87 Million
Previous $1.7 Billion 27.53%
% of portfolio
0.14%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$76.67 - $87.62 $462,473 - $528,523
6,032 Added 27.67%
27,835 $2.17 Billion
Q2 2024

Jul 26, 2024

BUY
$66.81 - $80.83 $501,609 - $606,871
7,508 Added 52.52%
21,803 $1.7 Billion
Q1 2024

May 07, 2024

BUY
$61.03 - $69.57 $254,617 - $290,246
4,172 Added 41.21%
14,295 $969 Million
Q4 2023

Feb 08, 2024

BUY
$61.89 - $69.28 $626,512 - $701,321
10,123 New
10,123 $682 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Atomi Financial Group, Inc. Portfolio

Follow Atomi Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atomi Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atomi Financial Group, Inc. with notifications on news.